FOXM1 augments sorafenib resistance and promotes progression of hepatocellular carcinoma by epigenetically activating KIF23 expression.
Biochem Biophys Res Commun
; 656: 1-9, 2023 05 14.
Article
in En
| MEDLINE
| ID: mdl-36940637
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Liver Neoplasms
Limits:
Humans
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2023
Type:
Article
Affiliation country:
China